guhjy's ccb [44 articles] Export

Recent papers added to guhjy's library classified by the tag ccb. You can also see everyone's ccb.

	Triple Antihypertensive Therapy With Amlodipine, Valsartan, and Hydrochlorothiazide: A Randomized Clinical Trial [My Copy] In Hypertension, Vol. 54, No. 1. (1 July 2009), pp. 32-39. by David A. Calhoun, Yves Lacourciere, Yann T. Chiang, Robert D. Glazer posted to diuretics combination ccb arb by guhjy on 2009-12-07 09:46:15 as
	Management of hypertension with the fixed combination of perindopril and amlodipine in daily clinical practice: results from the STRONG prospective, observational, multicenter study. [My Copy] American journal of cardiovascular drugs : drugs, devices, and other interventions, Vol. 9, No. 3. (2009), pp. 135-142. by Vinay K. Bahl, Uday M. Jadhav, Hemant P. Thacker posted to perindopril combination ccb bp by guhjy on 2009-12-04 03:52:48 as
	Influence of T-calcium channel blocker treatment on deterioration of renal function in chronic kidney disease. [My Copy] Heart and vessels, Vol. 24, No. 4. (1 July 2009), pp. 301-307. by Kiyotsugu Omae, Tetsuya Ogawa, Kosaku Nitta posted to ckd ccb by guhjy on 2009-11-16 05:04:14 as
	Optimization of hypertension management: the role of angiotensin receptor blocker-calcium channel blocker combinations. [My Copy] Journal of cardiovascular pharmacology, Vol. 53, No. 5. (May 2009), pp. 352-358. by Gianfranco Parati posted to combination ccb bp arb by guhjy on 2009-11-08 14:21:06 as
	Differential Effects Between a Calcium Channel Blocker and a Diuretic When Used in Combination With Angiotensin II Receptor Blocker on Central Aortic Pressure in Hypertensive Patients [My Copy] Hypertension, Vol. 54, No. 4. (1 October 2009), pp. 716-723. by Yoshio Matsui, Kazuo Eguchi, Michael F. O'Rourke, et al.Joji Ishikawa, Hiroshi Miyashita, Kazuyuki Shimada, Kazuomi Kario posted to rct olmesartan combination ccb by guhjy on 2009-11-08 13:14:54 as
	Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175,634 patients. [My Copy] Journal of hypertension, Vol. 27, No. 6. (June 2009), pp. 1136-1151. by Pierluigi Costanzo, Pasquale Perrone-Filardi, Mario Petretta, et al.Caterina Marciano, Enrico Vassallo, Paola Gargiulo, Stefania Paolillo, Andrea Petretta, Massimo Chiariello posted to meta-analysis cv ccb by guhjy on 2009-11-04 06:15:36 as
	Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials. [My Copy] Vascular health and risk management, Vol. 5, No. 1. (2009), pp. 411-427. by Gianpaolo Reboldi, Giorgio Gentile, Fabio Angeli, Paolo Verdecchia posted to rct dm diuretics combination ccb bp acei by guhjy on 2009-11-03 06:02:49 as
	Calcium antagonists: Do they equally protect against kidney injury? [My Copy] Kidney International, Vol. 73, No. 7. (01 April 2008), pp. 795-796. by P. Hart, G. L. Bakris posted to ckd ccb by guhjy on 2009-10-01 11:13:12 as
	Antihypertensives for kidney transplant recipients: systematic review and meta-analysis of randomized controlled trials. [My Copy] Transplantation, Vol. 88, No. 1. (15 July 2009), pp. 7-18. by Nicholas B. Cross, Angela C. Webster, Philip Masson, Philip J. O'connell, Jonathan C. Craig posted to rt meta-analysis ccb bp by guhjy on 2009-09-03 04:38:52 as
	Antihypertensive treatment for kidney transplant recipients. [My Copy] Cochrane database of systematic reviews (Online), No. 3. (2009) by Nicholas B. Cross, Angela C. Webster, Philip Masson, Philip J. O'Connell, Jonathan C. Craig posted to rt meta-analysis drug ccb bp acei by guhjy on 2009-09-03 04:36:21 as
	Role of angiotensin II, endothelin-1 and L-type calcium channel in the development of glomerular, tubulointerstitial and perivascular fibrosis. [My Copy] Journal of hypertension, Vol. 26, No. 10. (October 2008), pp. 2022-2029. by Teresa M. Seccia, Carmen Maniero, Anna S. Belloni, et al.Diego Guidolin, Poulose Pothen, Achille C. Pessina, Gian Paolo P. Rossi posted to kidney fibrosis et ccb aii by guhjy on 2009-08-15 04:57:52 as
	Nifedipine, a calcium channel blocker, inhibits advanced glycation end product (AGE)-elicited mesangial cell damage by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gamma activation. [My Copy] Biochemical and biophysical research communications, Vol. 385, No. 2. (24 July 2009), pp. 269-272. by Takanori Matsui, Sho-ichi Yamagishi, Masayoshi Takeuchi, Seiji Ueda, Kei Fukami, Seiya Okuda posted to ros rage pparg mc ccb age by guhjy on 2009-06-21 02:50:33 as
	Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial. [My Copy] Lancet, Vol. 365, No. 9463. (8 2005), pp. 939-946. by P. Ruggenenti, A. Perna, G. Loriga, et al.M. Ganeva, B. Ene-Iordache, M. Turturro, M. Lesti, E. Perticucci, I. N. Chakarski, D. Leonardis, G. Garini, A. Sessa, C. Basile, M. Alpa, R. Scanziani, G. Sorba, C. Zoccali, G. Remuzzi, posted to renoprotection acei bp ccb ndrd rct by guhjy on 2009-03-22 04:07:05 as along with 1 person brainsman2000
	A simplified approach to the treatment of uncomplicated hypertension: a cluster randomized, controlled trial. [My Copy] Hypertension, Vol. 53, No. 4. (23 April 2009), pp. 646-653. by Ross D. Feldman, Guang Y. Zou, Margaret K. Vandervoort, Cindy J. Wong, Sigrid A. Nelson, Brian G. Feagan posted to rct gdl combination ccb bp acei by guhjy on 2009-03-15 03:42:33 as
	Effects of calcium channel blockers on proteinuria in patients with diabetic nephropathy. [My Copy] Journal of clinical hypertension (Greenwich, Conn.), Vol. 10, No. 10. (October 2008), pp. 761-769. by Robert D. Toto, Min Tian, Kaffa Fakouhi, Annette Champion, Peter Bacher posted to dn combination ccb acei by guhjy on 2009-03-01 04:44:35 as
	Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial. [My Copy] Nature clinical practice. Nephrology, Vol. 3, No. 8. (August 2007), pp. 428-438. by R. W. Schrier, R. O. Estacio, P. S. Mehler, W. R. Hiatt posted to acei bp ccb dm rct uae by guhjy on 2009-02-26 05:32:12 as
	The Effect of Nisoldipine as Compared with Enalapril on Cardiovascular Outcomes in Patients with Non-Insulin-Dependent Diabetes and Hypertension [My Copy] N Engl J Med, Vol. 338, No. 10. (5 March 1998), pp. 645-652. by Raymond O. Estacio, Barrett W. Jeffers, William R. Hiatt, Stacy L. Biggerstaff, Nancy Gifford, Robert W. Schrier posted to risk-ratio abcd acei bp ccb dm rct by guhjy on 2009-01-25 14:20:21 as
	Managing hypertension in diabetic patients--focus on trandolapril/verapamil combination. [My Copy] Vascular health and risk management, Vol. 3, No. 4. (2007), pp. 453-465. by S. K. Sharma, P. Ruggenenti, G. Remuzzi posted to acei bp ccb dm rct by guhjy on 2009-01-20 14:04:39 as
	Trandolapril/verapamil sustained release: a review of its use in the treatment of essential hypertension. [My Copy] Drugs, Vol. 65, No. 13. (2005), pp. 1893-1914. by N. A. Reynolds, A. J. Wagstaff, S. J. Keam posted to acei bp ccb dm normoalbuminuria rct by guhjy on 2009-01-19 16:13:32 as
	Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. [My Copy] Lancet, Vol. 366, No. 9489. (6 2005), pp. 895-906. by B. Dahlöf, P. S. Sever, N. R. Poulter, et al.H. Wedel, D. G. Beevers, M. Caulfield, R. Collins, S. E. Kjeldsen, A. Kristinsson, G. T. McInnes, J. Mehlsen, M. Nieminen, E. O'Brien, J. Ostergren, posted to ascot bp ccb cv perindopril rct statin by guhjy on 2009-01-19 15:52:19 as
	Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial. [My Copy] American journal of kidney diseases : the official journal of the National Kidney Foundation, Vol. 48, No. 5. (November 2006), pp. 739-751. by K. Norris, J. Bourgoigne, J. Gassman, et al.L. Hebert, J. Middleton, R. A. Phillips, O. Randall, S. Rostand, S. Sherer, R. D. Toto, J. T. Wright, X. Wang, T. Greene, L. J. Appel, J. Lewis, posted to aask acei ccb cv proteinuria rct by guhjy on 2009-01-17 07:20:31 as
	Management of cardiovascular risk with RAS inhibitor/CCB combination therapy [My Copy] Journal of Human Hypertension, Vol. aop, No. current. by B. Dahlöf posted to acei arb bp ccb combination by guhjy on 2009-01-16 13:43:50 as
	Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. [My Copy] JAMA : the journal of the American Medical Association, Vol. 285, No. 21. (6 June 2001), pp. 2719-2728. by L. Y. Agodoa, L. Appel, G. L. Bakris, et al.G. Beck, J. Bourgoignie, J. P. Briggs, J. Charleston, D. Cheek, W. Cleveland, J. G. Douglas, M. Douglas, D. Dowie, M. Faulkner, A. Gabriel, J. Gassman, T. Greene, Y. Hall, L. Hebert, L. Hiremath, K. Jamerson, C. J. Johnson, J. Kopple, J. Kusek, J. Lash, J. Lea, J. B. Lewis, M. Lipkowitz, S. Massry, J. Middleton, E. R. Miller, K. Norris, D. O'Connor, A. Ojo, R. A. Phillips, V. Pogue, M. Rahman, O. S. Randall, S. Rostand, G. Schulman, W. Smith, D. Thornley-Brown, C. C. Tisher, R. D. Toto, J. T. Wright, S. Xu, posted to aask acei bp ccb ckd proteinuria rct by guhjy on 2009-01-13 15:15:00 as
	Comparison of effects of amlodipine and angiotensin receptor blockers on the intima-media thickness of carotid arterial wall (AAA study: amlodipine vs. ARB in atherosclerosis study). [My Copy] Diabetes research and clinical practice, Vol. 83, No. 1. (January 2009), pp. 50-53. by H. Ikeda, J. Minamikawa, Y. Nakamura, et al.S. Honjo, Y. Hamamoto, Y. Wada, K. Nabe, H. Koshiyama posted to arb atherosclerosis ccb rct by guhjy on 2009-01-13 14:29:36 as
	The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes. [My Copy] Journal of hypertension, Vol. 26, No. 11. (November 2008), pp. 2103-2111. by J. Ostergren, N. R. Poulter, P. S. Sever, et al.B. Dahlöf, H. Wedel, G. Beevers, M. Caulfield, R. Collins, S. E. Kjeldsen, A. Kristinsson, G. T. McInnes, J. Mehlsen, M. Nieminen, E. O'Brien, posted to ascot b-blocker bp ccb dm rct by guhjy on 2009-01-13 07:13:28 as
	Calcium channel blockers and renal protection: insights from the latest clinical trials. [My Copy] Journal of the American Society of Nephrology : JASN, Vol. 16 Suppl 1 (March 2005) by J. Segura, J. A. García-Donaire, L. M. Ruilope posted to aask ccb ckd rct by guhjy on 2009-01-01 14:22:41 as
	Blood Pressure Control with Amlodipine Add-on Therapy in Patients with Hypertension and Diabetes: Results of the Amlodipine Diabetic Hypertension Efficacy Response Evaluation Trial [My Copy] Ann Pharmacother, Vol. 42, No. 11. (1 November 2008), pp. 1552-1562. by Robert A. Kloner, Joel Neutel, Eli M. Roth, et al.Robert Weiss, Myron H. Weinberger, Kamlesh M. Thakker, Brian Schwartz, Harry Shi, Anne-Marie Gregg, The A. D. H. T. Investigators posted to bp ccb dm rct by guhjy on 2008-12-16 07:55:58 as
	Does It Matter How Hypertension Is Controlled? [My Copy] N Engl J Med, Vol. 359, No. 23. (4 December 2008), pp. 2485-2488. by Aram V. Chobanian posted to acei ccb diuretics rct by guhjy on 2008-12-16 05:58:50 as
	Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. [My Copy] The New England journal of medicine, Vol. 359, No. 23. (4 December 2008), pp. 2417-2428. by Kenneth Jamerson, Michael A. Weber, George L. Bakris, et al.Björn Dahlöf, Bertram Pitt, Victor Shi, Allen Hester, Jitendra Gupte, Marjorie Gatlin, Eric J. Velazquez, ACCOMPLISH Trial Investigators posted to rct diuretics combination ccb bp acei by guhjy on 2008-12-16 05:55:26 as along with 1 person jbhiatt
	Additional renoprotective effects of azelnidipine combined with angiotensin receptor blockers in patients with diabetic nephropathy. [My Copy] Clinical nephrology, Vol. Volume 70, No. November. (November 2008), pp. 385-392. by T Nakamura1, T Inoue2, N Fujiwara1, et al.Y Kawagoe1, T Sugaya3, Y Ueda4, H Koide5, K Node2 posted to renoprotection arb ccb dn by guhjy on 2008-11-27 08:26:23 as
	Cost-utility analysis of antihypertensive combination therapy in Japan by a Monte Carlo simulation model. [My Copy] Hypertension research : official journal of the Japanese Society of Hypertension, Vol. 31, No. 7. (July 2008), pp. 1373-1383. by I. Saito, M. Kobayashi, Y. Matsushita, A. Mori, K. Kawasugi, T. Saruta posted to arb bp ccb cea combination dn japan simulation by guhjy on 2008-11-05 07:12:06 as
	Renal protection in hypertensive patients: selection of antihypertensive therapy. [My Copy] Drugs, Vol. 65 Suppl 2 (2005), pp. 29-39. by René R. Wenzel posted to renoprotection ccb bp arb acei by guhjy on 2008-10-31 03:41:49 as
	Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: candesartan antihypertensive survival evaluation in Japan trial. [My Copy] Hypertension, Vol. 51, No. 2. (February 2008), pp. 393-398. by T. Ogihara, K. Nakao, T. Fukui, et al.K. Fukiyama, K. Ueshima, K. Oba, T. Sato, T. Saruta, posted to arb ccb cv rct by guhjy on 2008-10-31 03:28:34 as
	Potential risks of calcium channel blockers in chronic kidney disease. [My Copy] Current cardiology reports, Vol. 10, No. 6. (November 2008), pp. 448-455. by K. A. Griffin, A. K. Bidani posted to ccb ckd by guhjy on 2008-10-31 03:27:20 as
	The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study. [My Copy] Clinical therapeutics, Vol. 30, No. 3. (March 2008), pp. 482-498. by V. L. Esnault, E. A. Brown, E. Apetrei, et al.J. Bagon, C. Calvo, R. DeChatel, H. Holdaas, S. Krcmery, Z. Kobalava, posted to acei bp ccb ckd ndrd rct by guhjy on 2008-10-31 03:23:50 as
	Combination therapy with renin-angiotensin system inhibitors and the calcium channel blocker azelnidipine decreases plasma inflammatory markers and urinary oxidative stress markers in patients with diabetic nephropathy. [My Copy] Hypertension research : official journal of the Japanese Society of Hypertension, Vol. 31, No. 6. (June 2008), pp. 1147-1155. by S. Ogawa, T. Mori, K. Nako, S. Ito posted to acei arb ccb dn by guhjy on 2008-09-07 06:06:49 as
	Concomitant calcium entry blockade and inhibition of the renin-angiotensin system: a rational and effective means for treating hypertension. [My Copy] Journal of the renin-angiotensin-aldosterone system : JRAAS, Vol. 9, No. 1. (March 2008), pp. 1-9. by B. Gojanovic, F. Feihl, L. Liaudet, B. Waeber posted to acei arb bp ccb by guhjy on 2008-07-21 05:49:29 as
	Effect of amlodipine on cardiovascular events in hypertensive haemodialysis patients [My Copy] Nephrol. Dial. Transplant. (29 May 2008), gfn304. by Martin Tepel, Werner Hopfenmueller, Alexandra Scholze, Alexandra Maier, Walter Zidek posted to ccb cv hd by guhjy on 2008-07-08 05:45:57 as along with 1 person sebastien
	Are differences in calcium antagonists relevant across all stages of nephropathy or only proteinuric nephropathy? [My Copy] Current opinion in nephrology and hypertension, Vol. 16, No. 5. (September 2007), pp. 422-426. by J. Segura, J. A. García-Donaire, L. M. Ruilope posted to ccb ckd by guhjy on 2008-06-17 04:21:48 as
	Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial. [My Copy] Journal of the American Society of Nephrology : JASN, Vol. 17, No. 12. (1 December 2006), pp. 3472-3481. by Piero Ruggenenti, Annalisa Perna, Maria Ganeva, Bogdan Ene-Iordache, Giuseppe Remuzzi, BENEDICT Study Group posted to acei benedict bp ccb dn normoalbuminuria primary-prevention rct uae by guhjy on 2008-06-14 07:30:28 as
	Prevention of stroke and myocardial infarction by amlodipine and Angiotensin receptor blockers: a quantitative overview. [My Copy] Hypertension, Vol. 50, No. 1. (July 2007), pp. 181-188. by J. G. Wang, Y. Li, S. S. Franklin, M. Safar posted to arb ccb cv by guhjy on 2008-04-15 03:00:34 as
	Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study. [My Copy] Kidney international, Vol. 73, No. 11. (19 June 2008), pp. 1303-1309. by G. L. Bakris, R. D. Toto, P. A. McCullough, et al.R. Rocha, D. Purkayastha, P. Davis, GUARD (Gauging Albuminuria Reduction With Lotrel in Diabetic Patients With Hypertension) Study Investigators posted to rct proteinuria dn diuretics combination ccb acei by guhjy on 2008-03-22 03:15:36 as
	Metabolic and Clinical Outcomes in Non-Diabetic Individuals with the Metabolic Syndrome Assigned to Chlorthalidone, Amlodipine, or Lisinopril as Initial Treatment for Hypertension: A Report from the ALLHAT Study. [My Copy] Diabetes Care (13 November 2007) by Henry R R. Black, Barry Davis, Joshua Barzilay, et al.Chuke Nwachuku, Charles Baimbridge, Horia Marginean, Jackson T T. Wright, Jan Basile, Nathan D D. Wong, Paul Whelton, Richard A A. Dart, Udho Thadani posted to ndrd acei allhat ccb diuretics irs by guhjy on 2007-12-14 14:24:07 as
	Reduction of microalbuminuria in patients with type 2 diabetes: the Shiga Microalbuminuria Reduction Trial (SMART). [My Copy] Diabetes Care, Vol. 30, No. 6. (June 2007), pp. 1581-1583. by , T. Uzu, M. Sawaguchi, H. Maegawa, A. Kashiwagi posted to arb ccb dn japan rct uae by guhjy on 2007-10-23 09:01:10 as

Note: You may cite this page as: http://www.citeulike.org/user/guhjy/tag/ccb

ckd	1740
rct	1201
dn	1078
dm	1001
cancer	994
ma	970
cv	912
hd	860
tgfb	793
snp	760
bp	640
ros	571
meta-analysis	515
uae	499
stats	479
kidney	478
software	462
mouse	455
genetics	447
mirna	444
pt	417
proteomics	410
mortality	408
inflammation	364
fbl	359
rat	356
proteinuria	355
pcr	348
tw	345
gdl	331
acei	331
db	326
test	325
inhibitor	319
urine	315
arb	314
method	311
ms	310
apoptosis	302
hcv	300
mc	300
age	298
r	292
aging	289
biomarker	286
irs	282
akt	278
bias	277
ppi	277
bayes	275
mtor	270
aki	269
gwa	268
aii	261
hg	258
nutrition	255
rnai	242
emt	242
ub	239
p53	235
fibrosis	232
egfr	231
cox	226
obesity	223
smad	222
pbmc	220
pi3k	216
metab	213
drug	213
hcc	210
gn	208
1	205
hypoxia	204
herb	199
erk	191
albumin	189
lc	185
collagen	182
hif	179
longitudinal	179
nfkb	178
lmm	178
stz	176
gfr	174
pubmed	170
ua	170
epigenetics	169
japan	165
bioinf	164
power	163
p38	163
cea	163
gender	162
lead	160
rage	159
cadmium	158
dna-damage	157
ref	154
genomics	148
vitamin-d	148
stata	147
ctgf	144
network	143
liver	138
book	137
screening	137
rt	136
company	135
diet	134
seq	132
phosphorylation	130
protein	128
go	125
systems-biology	124
pathway	124
cell-cycle	123
esrd	123
kinase	122
no	121
mt	120
pkc	120
lipid	118
s6k	115
creatinine	115
statin	114
senescence	106
proliferation	106
podocyte	105
mapk	104
regression	103
fish	103
gfr-formula	102
case-control	102
cad	102
pd	102
imputation	101
multiplicity	100
imaging	99
insulin	98
observational	98
rx	97
plasmid	97
cloning	96
p21	95
pediatric	95
methylation	95
recurrent	94
sirt	93
blood	92
betel	91
tnf	90
nhanes	90
nox	90
chf	90
website	89
pparg	89
toxicology	88
phenotype	88
diagnosis	87
cytokine	87
src	87
anemia	87
immunity	86
stat	86
lr	86
uti	85
at1	84
china	83
epo	82
ebm	81
oat	81
ca	81
nonp	81
p	81
cachexia	80
hapmap	80
hypertrophy	80
environment	80
primer	78
gout	78
qms	77
review	75
autophagy	73
ko	73
gene-therapy	73
missing	73
promoter	73
lpd	72
gene-list	72
surrogate	72
eqtl	72
stone	72
p-value	71
mv	71
signaling	71
ace	71
salt	70
egf	69
phd	69
cox2	68
mgo	66
tin	66
uncertainty	66
normalization	65
mirna-target	65
chinese	65
gpcr	64
association	64
enddysf	63
causation	63
glycemia	63
yeast	63
foxo	63
2dge	63
acid-base	63
jnk	62
smoking	62
simulation	62
me	62
uuo	61
pla2	61
avf	61
confounding	61
ptm	61
hts	61
melamine	60
pe	60
infection	60
change	60
sas	60
outcome	60
cost	59
oral	59
eif	59
shc	59
ifn	59
crp	58
mmp	58
llcpk1	58
alcohol	58
fluorescence	57
nrk49f	57
robust	57
model-selection	57
pls	57
achr	57
urate-transporter	57
pai1	57
calibration	56
semantic	56
pdgf	56
hsp	56
aceiarb	56
hk2	56
oglcnac	55
goldstd	55
ratio	55
competing-risk	55
function	54
iron	54
stem-cell	54
estrogen	54
workflow	54
bone	54
ckd-progression	54
k	53
renoprotection	53
dipstick	53
std	53
dimerization	52
rho	52
qc	52
ace2	52
ncrna	52
histone	52
cyclin-d1	51
vegf	51
fgf	51
pth	51
epidemiology	51
normoalbuminuria	51
atm	51
lod	51
graph	50
risk-ratio	50
reasoning	50
arsenic	50
matlab	50
mercury	50
tf	49
gene-environment	49
hsc	49
ab	49
antibiotics	49
4ebp	49
epistasis	49
adpkd	49
ngal	48
ffpe	48
breakpoint	48
klotho	48
nrk52e	48
ukm	48
core-curriculum	48
pld	48
pooling	47
spot-urine	47
mesangial	47
joint-model	47
endothelium	47
hdac	46
translation	46
dub	46
aspirin	46
hgf	46
p27	46
il6	46
cystatin	46
fdr	46
ecm	46
protein-microarray	46
semip	45
wnt	45
writing	45
metal	45
fgf23	45
prevention	45
rapamycin	45
aldosterone	45
ras	44
biosensor	44
interaction	44
variability	44
ancova	44
ccb	44
diuretics	44
na	43
enos	43
klf	43
design	43
cnv	43
sle	43
bia	43
good	42
bmi	42
sumo	42
icu	42
roc	42
agreement	42
ampk	42
stroke	42
er-stress	41
tgfbr	41
risk	40
fuzzy	40
wga	40
hyperfiltration	40
gene-targeting	40
alignment	40
qtl	40
dbdb	40
igf	40
asia	39
dry-bw	39
urinalysis	39
hepatocyte	39
protein-complex	38
myc	38
tea	38
ap1	38
igan	38
angiogenesis	38
sage	38
adh	37
bh4	37
rvh	37
haplotype	37
hematuria	37
emr	37
antisense	37
fabp	37
mtorc1	37
propensity	37
tlr	37
animal	37
omics	36
rsk	36
adenosine	36
megalin	36
web20	36
inflammasome	36
catenin	36
cardiorenal	36
cre	35
calcification	35
adduct	35
chemogenomics	35
annotation	35
threshold	35
candidate-gene	35
gsk	35
proteasome	35
reverse-epidemiology	35
s100b	35
subgroup	35
msm	34
cross-species	34
exercise	34
coffee	34
pathology	34
sepsis	34
effect-size	34
nephrotoxicity	34
attrition	34
rca	33
ns	33
sp1	33
fibronectin	33
zeb	33
sarcopenia	33
snx	33
cage	33
ecology	33
integrin	33
il1	32
text-mining	32
end-point	32
addgene	32
orbitrap	32
affy	32
zfn	32
browser	32
risk-difference	31
macrophage	31
hospitalization	31
emsa	31
fc	31
transactivation	31
gllamm	31
set	31
abp	31
heritability	31
blast	31
frailty	31
rtk	31
family	31
vsmc	31
steroid	31
knockout	30
notch	30
silac	30
staging	30
transporter	30
bmp	30
mw	30
membrane-protein	30
carcinogen	30
creb	30
irs1	30
ai	29
validation	29
reporter	29
s100	29
perindopril	29
nutrient	29
grn	29
ub-ligase	29
3	29
extraction	29
nicotinic	29
virus	29
pka	29
et	29
geo	28
acetylation	28
time-dependent	28
scaling	28
gee	28
mutagenesis	28
race	28
human	27
mendelian	27
pdz	27
ce	27
cari	27
spla2	27
ndrd	27
thp	27
ck2	27
thesis	27
classification	27
mtorc2	27
peptide-microarray	26
gsh	26
renin	26
metagenomics	26
hba1c	26
muscarinic	26
agt	26

guhjy's ccb [44 articles] Export

guhjy's tags